Drug News in Cardiovascular area.

Drug News in Cardiovascular area. http://www.lifescience-online.com/ News Feed Powered by Lifescience-online.com en-us Wed, 08 Feb 2012 04:00:22 +0100 Wed, 08 Feb 2012 04:00:22 +0100 News Lifescience-online http://rss.lifescience-online.com/images/logo.gif http://www.lifescience-online.com/ Lifescience-online Athersys Announces Positive Results of MultiStem(R) Clinical Trial for Hematopoietic Stem Cell Transplant Support and Prevention of Graft-Versus-Host Disease http://www.lifescience-online.com/Athersys_Announces_Positive_Results_of_MultiStem_R,30772.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: ATHERSYS
Related drugs :: MULTISTEM

]]> Tue, 31 Jan 2012 23:00:00 GMT News Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera(R) Marketing Authorisation And Requests Further Information From the CHMP http://www.lifescience-online.com/Amsterdam_Molecular_Therapeutics_Announces_Europea,30745.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: AMSTERDAM MOLECULAR THERAPEUTICS
Related drugs :: ALIPOGENE TIPARVOVEC

]]> Sun, 29 Jan 2012 23:00:00 GMT News Lannett Company, Inc. (LCI) Receives FDA Approval for Hydrochlorothiazide Capsules, 12.5 mg http://www.lifescience-online.com/Lannett_Company__Inc___LCI__Receives_FDA_Approval_,30747.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: LANNETT CO INC
Related drugs :: HYDROCHLOROTHIAZIDE

]]> Sun, 29 Jan 2012 23:00:00 GMT News BTG Announces Positive Data from First US Phase III Trial of Varisolve(R) http://www.lifescience-online.com/BTG_Announces_Positive_Data_from_First_US_Phase_II,30749.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: BTG PLC
Related drugs :: VARISOLVE

]]> Sun, 29 Jan 2012 23:00:00 GMT News Juventas Therapeutics, Inc. Reports One Year Data From Phase I Heart Failure Clinical Trial http://www.lifescience-online.com/Juventas_Therapeutics__Inc__Reports_One_Year_Data_,30785.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: JUVENTAS THERAPEUTICS INC
Related drugs :: JVS-100

]]> Sun, 29 Jan 2012 23:00:00 GMT News New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease http://www.lifescience-online.com/New_FDA_Approved_Labeling_For_VYTORIN___Ezetimibe_,30711.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: MERCK AND CO INC
Related drugs :: EZETIMIBE + SIMVASTATIN

]]> Tue, 24 Jan 2012 23:00:00 GMT News Amorcyte Inc., a NeoStem, Inc. Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction http://www.lifescience-online.com/Amorcyte_Inc___a_NeoStem__Inc__Company__Enrolls_Fi,30761.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: AMORCYTE INC
NEOSTEM INC
Related drugs :: AMR-001

]]> Tue, 24 Jan 2012 23:00:00 GMT News MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) and Licensee ERCell Receive Russian Regulatory Approval for the RECOVER-ERC Trial http://www.lifescience-online.com/MediStem__Inc___Formerly_known_as_Medistem_Laborat,30724.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: Medistem Inc
Related drugs :: ENDOMETRIAL REGENERATIVE CELLS

]]> Sun, 22 Jan 2012 23:00:00 GMT News